What it sells
Independent hair transplant facilitator matching patients with vetted clinics abroad and in the US.
Business model breakdown
Buyer: who owns the budget?
The patient pays directly, in USD, with payment plans up to 36 months.
Trigger: what makes them buy now?
High local price of hair transplants and the risk of choosing unsafe clinics abroad; site claims local patients pay extra card fees, FX fees and foreigner surcharges.
Workflow: what inputs become what output?
Match to clinic, USD pricing, travel arrangement, US aftercare.
Economics: what it saves and how it charges
UnverifiedNegotiates volume rates with vetted clinics and quotes the patient a standardized USD package; Doctours presumably keeps the spread or a clinic commission (not stated).
Distribution: how it reaches customers
Consumer web funnel: Get matched with a clinic.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-07 | Pre-seed | $2M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.